Lorus Therapeutics Inc.
2 Meridian Road
Toronto
Ontario
M9W 4Z7
Canada
Tel: 416-798-1200
Fax: 416-798-2200
Website: http://www.lorusthera.com/
Email: info@lorusthera.com
129 articles about Lorus Therapeutics Inc.
-
Lorus Therapeutics Inc. Implements Name Change To Aptose Biosciences
9/2/2014
-
Lorus Therapeutics Inc. Announces Results Of Annual And Special Meeting Of Shareholders
8/20/2014
-
Lorus Therapeutics Inc. To Present At The Canaccord Genuity 34th Annual Growth Conference
8/7/2014
-
Lorus Therapeutics Inc. Receives FDA Clearance Of IND To Initiate LOR-253 Clinical Program In Patients With AML, MDS And Other Blood Cancers
7/28/2014
-
Lorus Therapeutics Inc. To Host Fourth Quarter And Year End 2014 Financial Results Conference Call And Webcast
7/14/2014
-
Lorus Therapeutics Inc. Provides Update On Warrants
6/10/2014
-
Lorus Therapeutics Inc. To Present Data On Lead Compound LOR-253 At American Association for Cancer Research Annual Meeting 2014
4/4/2014
-
Lorus Therapeutics Inc.'s President And COO To Step Down
3/20/2014
-
Lorus Therapeutics Inc. Completes New Executive Management Team
12/2/2013
-
Lorus Therapeutics Inc. to Focus LOR-253 Development on AML Based on Genetic Insights into the Causes of Certain Hematologic Cancers
10/29/2013
-
Lorus Therapeutics Inc. Appoints New Chief Executive Officer
10/28/2013
-
Lorus Therapeutics Inc. Signs Research and License Option Agreement With Elanco
4/17/2013
-
Lorus Therapeutics Inc. Presents Positive Data for Lead Anticancer Drug LOR-253
4/3/2012
-
Lorus Therapeutics Inc. Announces Positive Results from Its Small Molecule Antimicrobial Program
3/27/2012
-
Lorus Therapeutics Inc. Reports Second Quarter Results for Fiscal Year 2011
1/14/2011
-
Lorus Therapeutics Inc. Enrolls First Patient in Phase I Clinical Study of Anticancer Drug LOR-253
1/13/2011
-
Lorus Therapeutics Inc. Closes Private Placement for Gross Proceeds of $1.66 Million
12/1/2010
-
Lorus Therapeutics Inc. Completes Rights Offering, Raising $4.6 Million
11/10/2010
-
Lorus Therapeutics Inc. Announces Allowance of United States Patent for Lead Antimicrobial Small Molecule
10/21/2010
-
Lorus Therapeutics Inc. Reports First Quarter Results for Fiscal Year 2011
10/15/2010